SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Brugada Josep)
 

Sökning: WFRF:(Brugada Josep) > Contemporary manage...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00004963naa a2200517 4500
001oai:DiVA.org:uu-322685
003SwePub
008170529s2017 | |||||||||||000 ||eng|
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3226852 URI
0247 a https://doi.org/10.1093/eurheartj/ehw5642 DOI
040 a (SwePub)uu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
1001 a Arbelo, Elenau Univ Barcelona, Hosp Clin Barcelona, Cardiovasc Inst, Dept Cardiol, Barcelona, Spain.4 aut
2451 0a Contemporary management of patients undergoing atrial fibrillation ablation :b in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry
264 c 2017-01-18
264 1b Oxford University Press,c 2017
338 a print2 rdacarrier
520 a Aims The ESC-EHRA Atrial Fibrillation Ablation Long-Term registry is a prospective, multinational study that aims at providing an accurate picture of contemporary real-world ablation for atrial fibrillation (AFib) and its outcome. Methods and results A total of 104 centres in 27 European countries participated and were asked to enrol 20-50 consecutive patients scheduled for first and re-do AFib ablation. Pre-procedural, procedural and 1-year follow-up data were captured on a web-based electronic case record form. Overall, 3630 patients were included, of which 3593 underwent an AFib ablation (98.9%). Median age was 59 years and 32.4% patients had lone atrial fibrillation. Pulmonary vein isolation was attempted in 98.8% of patients and achieved in 95-97%. AFib-related symptoms were present in 97%. Inhospital complications occurred in 7.8% and one patient died due to an atrioesophageal fistula. One-year follow-up was performed in 3180 (88.6%) at a median of 12.4 months (11.9-13.4) after ablation: 52.8% by clinical visit, 44.2% by telephone contact and 3.0% by contact with the general practitioner. At 12-months, the success rate with or without antiarrhythmic drugs (AADs) was 73.6%. A significant portion (46%) was still on AADs. Late complications included 14 additional deaths (4 cardiac, 4 vascular, 6 other causes) and 333 (10.7%) other complications. Conclusion AFib ablation in clinical practice is mostly performed in symptomatic, relatively young and otherwise healthy patients. Overall success rate is satisfactory, but complication rate remains considerable and a significant portion of patients remain on AADs. Monitoring after ablation shows wide variations. Antithrombotic treatment after ablation shows insufficient guideline-adherence.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng
653 a Atrial fibrillation
653 a Ablation
653 a Prospective registry
653 a Management
653 a Outcomes
653 a Complications
7001 a Brugada, Josepu Univ Barcelona, Hosp Clin Barcelona, Cardiovasc Inst, Dept Cardiol, Barcelona, Spain.4 aut
7001 a Blomström-Lundqvist, Carinau Uppsala universitet,Kardiologi4 aut0 (Swepub:uu)carinabl
7001 a Laroche, Cecileu European Soc Cardiol, EURObservat Res Programme, Sophia Antipolis, France.4 aut
7001 a Kautzner, Josefu Inst Clin & Expt Med, Dept Cardiol, Prague, Czech Republic.4 aut
7001 a Pokushalov, Evgenyu State Res Inst Circulat Pathol, Arrhythmia Dept, Novosibirsk, Russia.;State Res Inst Circulat Pathol, EP Lab, Novosibirsk, Russia.4 aut
7001 a Raatikainen, Pekkau Tampere Univ Hosp, Heart Ctr Co, Tampere, Finland.4 aut
7001 a Efremidis, Michaelu Evangelismos Gen Hosp Athens, Lab Cardiac Electrophysiol, Dept Cardiol 2, Athens, Greece.4 aut
7001 a Hindricks, Gerhardu Univ Leipzig, Ctr Heart, Dept Electrophysiol, Leipzig, Germany.4 aut
7001 a Barrera, Albertou Univ Hosp Virgen de la Victoria, Dept Cardiol, Arrhythmia Unit, Malaga, Spain.4 aut
7001 a Maggioni, Aldou European Soc Cardiol, EURObservat Res Programme, Sophia Antipolis, France.;Assoc Nazl Med Cardiol Osped Res Ctr AMCO Res Ctr, Florence, Italy.4 aut
7001 a Tavazzi, Luigiu Maria Cecilia Hosp, ES Hlth Sci Fdn, GVM Care & Res, Cotignola, Italy.4 aut
7001 a Dagres, Nikolaosu Univ Leipzig, Ctr Heart, Dept Electrophysiol, Leipzig, Germany.4 aut
7102 a Univ Barcelona, Hosp Clin Barcelona, Cardiovasc Inst, Dept Cardiol, Barcelona, Spain.b Kardiologi4 org
7730 t European Heart Journald : Oxford University Pressg 38:17, s. 1303-1316q 38:17<1303-1316x 0195-668Xx 1522-9645
8564 u https://academic.oup.com/eurheartj/article-pdf/38/17/1303/14018251/ehw564.pdf
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-322685
8564 8u https://doi.org/10.1093/eurheartj/ehw564

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy